[1]
Tanimoto Duque, F.A. et al. 2022. Evaluation of pediatric hydroxyurea prescriptions for patients with sickle cell disease: 10.15343/0104-7809.202246369379I. O Mundo da Saúde. 46, (Nov. 2022), 369–379.